Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Oral Oncology|July 4, 2012
Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancerMissak Haigentz, Mimi Kim, Catherine Sarta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Clinical and molecular responses in lung cancer patients receiving RomidepsinDavid S Schrump, Maria R Fischette, Dao M Nguyen, et al.
Blood|November 4, 2006
A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemiaJeffrey E Lancet, Ivana Gojo, Jason Gotlib, et al.
Cancer Chemotherapy and Pharmacology|June 24, 2021
Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumorsWilliam F Maguire, John C Schmitz, Jonas Scemama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancerJoseph A Sparano, Stacy Moulder, Aslamuzzaman Kazi, et al.
Leukemia Research|December 8, 2009
Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemiaJudith E Karp, Amanda Blackford, B Douglas Smith, et al.
Clinical Colorectal Cancer|April 12, 2015
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal CancerKhanh Do, Liang Cao, Zhigang Kang, et al.
British Journal of Haematology|February 18, 2009
Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre Phase 2 clinical trialOwen A O'Connor, Craig Moskowitz, Carol Portlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2014
A phase i study of DMS612, a novel bifunctional alkylating agentLeonard J Appleman, Sanjeeve Balasubramaniam, Robert A Parise, et al.
The Oncologist|March 26, 2017
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi SarcomaThomas S Uldrick, Priscila H Gonçalves, Kathleen M Wyvill, et al.
Pageof 15